Decoding neoantigen-encoding tumor-specific transcripts unveils a shared target reservoir for immunotherapy in hepatocellular carcinoma. [PDF]
Lin P +13 more
europepmc +1 more source
Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics. [PDF]
Ye L +8 more
europepmc +1 more source
Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patients. [PDF]
Zhang B +14 more
europepmc +1 more source
Mechanistic biomarkers for cancer vaccine development: from cancer cell biology to neoantigen-guided precision immunotherapy. [PDF]
Rusciano D.
europepmc +1 more source
Whole-Exome Sequencing to Screen Personal Neoantigens With High Immunogenicity in Patients With Microsatellite Stability (MSS)-Advanced Colorectal Cancer. [PDF]
Li D +7 more
europepmc +1 more source
DEA hypothesis: disinhibition, enhancing recognition, and alerting the host are the three pillars of effective cancer immunotherapy. [PDF]
Wang XS, Lotze MT.
europepmc +1 more source
Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies. [PDF]
Mhanna D +9 more
europepmc +1 more source
From Disposal to Display: Crinophagy as a β-Cell Source of Neoantigens in Type 1 Diabetes. [PDF]
Zou AJ, Wan X.
europepmc +1 more source
Head and neck cancer therapeutic vaccines: a review. [PDF]
Huetteman A, Rabinowits G.
europepmc +1 more source
Generation of Regulatory T Cells Against Islet Neoantigen. [PDF]
Den Hollander NHM +6 more
europepmc +1 more source

